inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.
about
Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-AnalysisMolecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia.Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy.The Globalization of Cooperative Groups.Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors.Go retro and get a GRIP.Application of the AMLprofiler Diagnostic Microarray in the South African Setting.Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm.Prevalence and Clinical Significance of FLT3 and NPM1 Mutations in Acute Myeloid Leukaemia Patients of Assam, India.Recurrent Cytogenetic Abnormalities in Acute Myeloid Leukemia.Acute myeloid leukemia with inv(16)(p13.1q22), abnormal eosinophils, and absence of peripheral blood and bone marrow blasts.
P2860
Q26771740-2DE1C694-B705-4BD6-8DE3-B3D4D745C9D7Q30252938-233A98B5-051D-425F-B15F-7BA4659A41B8Q34663691-A0179A84-6D6F-4C68-9908-42C5DAD7763BQ36119749-6860956F-1579-4BCF-BA1C-62B92FBAF487Q38263126-9600A2E5-057B-4DD6-94B6-74105D13540CQ41000254-1125D0E0-C2AF-4123-A8A5-586859D88E14Q47102086-4D4BEAE7-8527-42E7-B95F-BE564841F916Q48171349-70CE4523-64CB-42C7-B126-8C0B4487E49BQ49338358-8EEA5B51-ABFD-4E2D-B543-2F14840B2E4FQ52817300-529ECB78-0712-4B52-8359-D52D58E715CDQ53224430-16CA0032-6651-4109-8709-E17DE9A98DCD
P2860
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
inv(16)/t(16;16) acute myeloid ...... atures and lack KIT mutations.
@ast
inv(16)/t(16;16) acute myeloid ...... atures and lack KIT mutations.
@en
type
label
inv(16)/t(16;16) acute myeloid ...... atures and lack KIT mutations.
@ast
inv(16)/t(16;16) acute myeloid ...... atures and lack KIT mutations.
@en
prefLabel
inv(16)/t(16;16) acute myeloid ...... atures and lack KIT mutations.
@ast
inv(16)/t(16;16) acute myeloid ...... atures and lack KIT mutations.
@en
P2093
P2860
P50
P1433
P1476
inv(16)/t(16;16) acute myeloid ...... atures and lack KIT mutations.
@en
P2093
Alliance for Clinical Trials in Oncology
Andrew J Carroll
Ann-Kathrin Eisfeld
Colin G Edwards
Deedra Nicolet
Heiko Becker
John Curfman
Jonathan E Kolitz
Mark J Pettenati
Michael A Caligiuri
P2860
P304
P356
10.1182/BLOOD-2012-07-442772
P407
P50
P577
2012-11-16T00:00:00Z